...
首页> 外文期刊>Analytical and bioanalytical chemistry >SERS spectroscopy using Au-Ag nanoshuttles and hydrophobic paper-based Au nanoflower substrate for simultaneous detection of dual cervical cancer-associated serum biomarkers
【24h】

SERS spectroscopy using Au-Ag nanoshuttles and hydrophobic paper-based Au nanoflower substrate for simultaneous detection of dual cervical cancer-associated serum biomarkers

机译:使用Au-Ag纳米型和疏水性纸型Au纳米λ底物的SERS光谱,用于同时检测双宫颈癌相关血清生物标志物

获取原文
获取原文并翻译 | 示例
           

摘要

Ultrasensitive detection of specific biomarkers in clinical serum is helpful for early diagnosis of cervical cancer. In this paper, a surface-enhanced Raman scattering (SERS)-based immunoassay was developed for the simultaneous determination of squamous cell carcinoma antigen (SCCA) and osteopontin (OPN) in cervical cancer serum. Au-Ag nanoshuttles (Au-AgNSs) as SERS tags and hydrophobic filter paper-based Au nanoflowers (AuNFs) as capture substrate were constructed into a sandwich structure which served as an ultrasensitive SERS-based immunoassay platform. Finite difference time domain simulation confirmed that the electromagnetic field coupled between the AuNFs had a prominent SERS signal enhancement effect, which improved the detection sensitivity. SERS mapping showed that hexadecenyl succinic anhydride hydrophobic treatment could prevent the analyte from being quickly absorbed by the filter paper and increase the retention time to be more evenly distributed on the filter paper substrate. The immunoassay platform was verified to have good selectivity and reproducibility. With this method, the detection limits of SCCA and OPN in human serum were as low as 8.628 pg/mL and 4.388 pg/mL, respectively. Finally, in order to verify the feasibility of its clinical application, the serum samples of healthy subjects; cervical intraepithelial neoplasia I (CINI), CINII, and CINIII; and cervical cancer patients were analyzed, and the reliability of the results was confirmed by enzyme-linked immunosorbent assay experiments. The constructed SERS-based immunoassay platform could be used as a clinical tool for early screening of cancers in the future.
机译:临床血清中特定生物标志物的超敏检测有助于早期诊断宫颈癌。在本文中,开发了一种表面增强的拉曼散射(SERS),用于同时测定宫颈癌血清中鳞状细胞癌抗原(SCCA)和骨桥蛋白(OPN)。 AU-AG纳米型(AU-AGNS)作为SERS标签和疏水式滤纸的AU纳米割草(AUNFS)作为捕获基材构成为夹层结构,其用作超敏SERS的免疫测定平台。有限差分时域模拟证实,AUNFS之间耦合的电磁场具有突出的SERS信号增强效果,其提高了检测灵敏度。 Sers Mappping表明,十六烯基琥珀酸酐疏水处理可以防止分析物通过滤纸迅速吸收,并增加滤纸上更均匀地分布的保留时间。验证了免疫分析平台以具有良好的选择性和再现性。通过该方法,人血清中SCCA和OPN的检测限分别低至8.628pg / ml和4.388pg / ml。最后,为了验证其临床应用的可行性,健康受试者的血清样本;宫颈上皮内瘤瘤I(CINI),CINII和CINIII;分析了宫颈癌患者,通过酶联免疫吸附测定实验证实了结果的可靠性。基于结构的基于SERS的免疫测定平台可用作未来早期筛查癌症的临床工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号